Self-Study 2025 Release I: Anxiety and Depression in Adult Survivors of Cancer
Survivorship for persons with cancer includes promotion of good health practices, surveillance for cancer recurrence or progression, and prevention and treatment of toxicities, including psychosocial distress. The presence of psychosocial distress, including anxiety and depression, may negatively impact patient outcomes and QoL. Disease, treatment, and socioeconomic factors influence anxiety and depression in adult persons with cancer. In this module, participants will explore risk factors and contributors to anxiety and depression in adult persons with cancer, identify scoring tools for assessment, and review data surrounding pharmacologic and non-pharmacologic treatment modalities to address anxiety and depression, including the utilization of cannabis.
Anxiety and Depression in Adult Survivors of Cancer
UAN#: 0465-0000-25-068-H99-P
Author: Lisa Grate, PharmD, MS, BCOP, BCPS
Learning Objectives
- Recognize risk factors, including disease, treatment and socioeconomic factors, that contribute to anxiety and depression in adult survivors of cancer
- Using validated assessment tools for anxiety and depression, formulate a therapeutic plan for addressing and monitoring anxiety and depression in adult survivors of cancer
- Develop recommendations regarding for the safe use of cannabis for anxiety and depression in adult survivors with cancer based on current evidence
Get it here
Knowledge Course for Pharmacists
Technology requirements: HOPA Learn requires a modern web browser (Internet Explorer 7+, Mozilla Firefox, Apple Safari, Google Chrome) and the ability to listen to audio with the content.
HOPA is accredited by the Accreditation Council for Pharmacy Education as a provider of continuing pharmacy education. In order to claim BCOP credit, you must pass the BCOP Post-Test with a 75% or higher.
All CE hours will be transmitted to the CPE Monitor and BPS within 1-2 weeks of course completion.